Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 5 hours ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

S4987Referred to Committee

A bill to require the Federal Trade Commission to submit a report on foreign investment in the pharmaceutical industry of the United States, and for other purposes.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-07-15
Introduced
2
Cosponsors
S
ⓘ
Type

Sponsor

Elizabeth Warren
Elizabeth Warren
Democrat · MA · Senator
Votes with party: 85.2% (844 recorded votes)

Full profile: /officials/W000817

Source: Congress.gov · FEC

Cosponsors (2)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Kirsten E. Gillibrand (D-NY)Original· 2026-07-15
  • Rick Scott (R-FL)Original· 2026-07-15

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

2026-07-15

Source: Congress.gov

Committee Activity

Currently in

  • Senate Committee on Banking, Housing, and Urban AffairsReferred To · 2026-07-15

Plain-English Summary

The Federal Trade Commission would be required to investigate and report on how much foreign companies and investors own or control in the U.S. pharmaceutical industry, including what types of drugs and medicines they're involved with. This report would help Congress understand whether foreign investment in American drug companies could affect drug prices, availability, or national security. The information would be useful for lawmakers deciding whether new rules are needed to protect American interests in the pharmaceutical sector.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • S4986Mamas First Act
    Referred to Committee · 2026-07-15
  • S4946Health and Location Data Protection Act of 2026
    Referred to Committee · 2026-07-13
  • S4734Critical Defense Ownership Review Act
    Referred to Committee · 2026-06-10
  • S4743AI Bubble Transparency Act
    Referred to Committee · 2026-06-10